{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":51,"n_cols":5,"rows_kept":51,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[13,2,13,3],[18,2,18,3],[19,2,19,3],[23,2,23,3],[25,2,25,3],[25,4,25,5],[26,2,26,3],[26,4,26,5],[27,2,27,3],[27,4,27,5],[28,2,28,3],[29,2,29,3],[38,2,38,3],[39,2,39,3],[40,2,40,3],[41,2,41,3],[43,2,43,3],[44,2,44,3],[48,2,48,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9911020178603321"]
[null,null,"Titolo",null,"Managing complexity in global organizations / / Ulrich Steger, Wolfgang Amann, Martha Maznevski [editors]"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, West Sussex, England ; ; Hoboken, N.J., : John Wiley & Sons, c2007"]
[null,null,"ISBN",null,"9786610839575"]
[{"$nulls":4},"9781119208419"]
[{"$nulls":4},"1119208416"]
[{"$nulls":4},"9781280839573"]
[{"$nulls":4},"1280839570"]
[{"$nulls":4},"9780470513118"]
[{"$nulls":4},"047051311X"]
[null,null,"Descrizione fisica",null,"1 online resource (313 p.)"]
[null,null,"Collana",null,"IMD Executive Development Series ; ; v.5"]
[null,null,"Disciplina",null,"658/.049"]
[null,null,"Soggetti",null,"International business enterprises - Management"]
[{"$nulls":4},"Corporate culture"]
[{"$nulls":4},"Technological innovations - Management"]
[{"$nulls":4},"Business logistics - Management"]
[{"$nulls":4},"Diversity in the workplace - Management"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"pt. 1. Conceptual framework and trends on the macro-level -- pt. 2. Impact of changes in the competitive landscape and business models on selected industries -- pt. 3. Solutions for managing complexity on the functional level -- pt. 4. Additional complexity challenges."]
[null,null,null,"Sommario/riassunto","This book delivers new IMD insights on an emerging challenge - how to deal with overwhelming complexity. Global organizations face a complex decision-making environment. On one side, diversity of cultures, customers, competitors and regulations creates complexity; on the other, competitive pressures cause expanding countries to extract more synergies across products and regions. In such a climate, a new way of thinking, acting and organizing is needed beyond the familiar 'control' mindset. Drawing together insights from across the expert faculty, Managing Complexity in the Global Organiza"]
[null,"2.","Record Nr.",null,"UNINA9910954561303321"]
[null,null,"Autore",null,"Jackson Emily <1966->"]
[null,null,"Titolo",null,"Law and the regulation of medicines / / Emily Jackson"]
[null,null,"Pubbl/distr/stampa",null,"Oxford ; ; Portland, Ore. : , : Hart Publishing, , 2012"]
[null,null,"ISBN",null,"9786613851970"]
[{"$nulls":4},"9781847319098"]
[{"$nulls":4},"1847319092"]
[{"$nulls":4},"9781474200776"]
[{"$nulls":4},"147420077X"]
[{"$nulls":4},"9781283539524"]
[{"$nulls":4},"1283539527"]
[{"$nulls":4},"9781847319081"]
[{"$nulls":4},"1847319084"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (308 p.)"]
[null,null,"Disciplina",null,"344.410416"]
[null,null,"Soggetti",null,"Drugs - Law and legislation - Great Britain"]
[{"$nulls":4},"Pharmacy - Law and legislation - Great Britain"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (pages 267-292)."]
[null,null,"Nota di contenuto",null,"What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement."]
[null,null,null,"Sommario/riassunto","\"The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine's regulation are examined separately: first, pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and second, the possibility of using medicines to enhance well-being or performance, rather than treat disease. Throughout, the emphasis is on "]
[{"$nulls":4},"the role of regulation in shaping and influencing the operation of the medicines industry, an issue that is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources.\"--Bloomsbury Publishing."]